Does the CPS1 rs1047891 (T1405N) variant reduce urea production and lower blood urea nitrogen at a given protein intake?

The CPS1 rs1047891 (T1405N) variant significantly influences the urea cycle's efficiency, impacting how the body processes nitrogen from dietary protein. As the rate-limiting enzyme for the urea cycle, CPS1 (carbamoyl phosphate synthetase 1) is responsible for the critical first step of ammonia detoxification: the conversion of ammonia and bicarbonate into carbamoyl phosphate.

Mechanistic evidence

The rs1047891 variant involves a threonine-to-asparagine substitution at position 1405, a domain essential for the enzyme's catalytic function.

• Enzymatic Activity: This polymorphism is a functional SNP (single nucleotide polymorphism). Evidence from metabolic studies indicates that carriers of specific alleles (notably the A-allele) exhibit dysregulated CPS1 expression and potentially reduced enzymatic throughput.
• Flux Regulation: Because CPS1 governs the entry of nitrogen into the urea cycle, any reduction in its activity directly limits the total urea cycle flux. While specific kinetic data for the T1405N variant's Vmax are not always isolated, general findings for CPS1 missense mutations show they often impair thermal stability and substrate affinity, leading to a diminished rate of urea synthesis from amino acid-derived nitrogen.

Clinical and physiological findings

The primary clinical manifestation of reduced CPS1 activity is a modification of nitrogen metabolic markers.

• Blood Urea Nitrogen (BUN): BUN levels serve as a biological signature of urea cycle activity and protein loading. High protein intake typically upregulates CPS1 via pathways like AMPK to manage the increased ammonia load.
• Interactions with Protein Intake: Because the rs1047891 variant reduces the efficiency of the urea synthesis pathway, individuals with this variant may produce less urea for a given amount of ingested protein compared to those with the wild-type enzyme. This results in lower baseline BUN levels despite similar dietary protein consumption.
• Metabolic Context: These effects are particularly pronounced in metabolic stress environments, such as non-alcoholic fatty liver disease (NAFLD), where the variant has been linked to altered metabolic health and renal dysfunction markers.

Bottom line

The CPS1 rs1047891 (T1405N) variant is a functional genetic factor that can reduce urea cycle flux. By lowering the efficiency of the rate-limiting step in ammonia detoxification, it leads to decreased urea production and consequently lower blood urea nitrogen levels at a given protein intake.